1. Home
  2. PSTV vs UPXI Comparison

PSTV vs UPXI Comparison

Compare PSTV & UPXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • UPXI
  • Stock Information
  • Founded
  • PSTV 1996
  • UPXI 2018
  • Country
  • PSTV United States
  • UPXI United States
  • Employees
  • PSTV N/A
  • UPXI N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • UPXI Medicinal Chemicals and Botanical Products
  • Sector
  • PSTV Health Care
  • UPXI Health Care
  • Exchange
  • PSTV Nasdaq
  • UPXI Nasdaq
  • Market Cap
  • PSTV 17.0M
  • UPXI 481.8M
  • IPO Year
  • PSTV N/A
  • UPXI 2021
  • Fundamental
  • Price
  • PSTV $0.42
  • UPXI $6.09
  • Analyst Decision
  • PSTV Strong Buy
  • UPXI
  • Analyst Count
  • PSTV 4
  • UPXI 0
  • Target Price
  • PSTV $7.88
  • UPXI N/A
  • AVG Volume (30 Days)
  • PSTV 5.6M
  • UPXI 6.0M
  • Earning Date
  • PSTV 11-13-2025
  • UPXI 05-16-2025
  • Dividend Yield
  • PSTV N/A
  • UPXI N/A
  • EPS Growth
  • PSTV N/A
  • UPXI N/A
  • EPS
  • PSTV N/A
  • UPXI N/A
  • Revenue
  • PSTV $5,317,000.00
  • UPXI $16,562,327.00
  • Revenue This Year
  • PSTV $28.09
  • UPXI N/A
  • Revenue Next Year
  • PSTV N/A
  • UPXI $147.95
  • P/E Ratio
  • PSTV N/A
  • UPXI N/A
  • Revenue Growth
  • PSTV N/A
  • UPXI 1378.83
  • 52 Week Low
  • PSTV $0.16
  • UPXI $1.90
  • 52 Week High
  • PSTV $2.31
  • UPXI $22.57
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 41.60
  • UPXI 46.89
  • Support Level
  • PSTV $0.40
  • UPXI $5.20
  • Resistance Level
  • PSTV $0.52
  • UPXI $6.84
  • Average True Range (ATR)
  • PSTV 0.05
  • UPXI 0.65
  • MACD
  • PSTV -0.01
  • UPXI -0.09
  • Stochastic Oscillator
  • PSTV 15.65
  • UPXI 23.35

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About UPXI Upexi Inc.

Upexi Inc specializes in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space via a Solana treasury strategy.

Share on Social Networks: